Role of Prolactin-Induced Protein (PIP) in breast cancer progression using an adjuvant therapy.
2016/23/B/NZ5/02647
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 8
Call
OPUS 12 – announced on 2016-09-15
- Amount awarded
- 1 885 870 PLN
- Project start date
- 2017-08-11
- Project end date
- 2021-08-10
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Mikroskop odwrócony OLYMPUS IX83 (495000 pcs). Cost: 495 000 PLN
Information in the final report
Publication in academic press/journals (2)
-
Prolactin‐induced protein (PIP) increases the sensitivity of breast cancer cells to drug‐induced apoptosis
- Authors:
- Anna Urbaniak, Karolina Jabłońska, Jarosław Suchański, Aleksandra Partyńska, Katarzyna Szymczak-Kulus, Rafał Matkowski, Adam Maciejczyk, Maciej Ugorski, Piotr Dzięgiel
- Academic press:
- Scientific Reports (year: 2023, volume: 13, pages: 6574), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1038/s41598-023-33707-w – link to the publication
-
Prolactin-induced protein (PIP) Characterization and role in breast cancer progression.
- Authors:
- Anna Urbaniak, Karolina Jabłońska, Marzenna Podhorska-Okołów, Maciej Ugorski, Piotr Dzięgiel
- Academic press:
- American Journal of Cancer Research (year: 2018, volume: 8, pages: 2150-2164), Publisher: e-century Publishing Corporation
- Status:
- Published